Table 3.
TTP and average dosage for delayed-IADT,
I
ADT and standard IADT.
Patient001 (responsive) | Patient011 (resistant) | |||||
---|---|---|---|---|---|---|
delayed-I2ADT | I2ADT | IADT | delayed-I2ADT | I2ADT | IADT | |
TTP (month) | 120 | 120 | 115 | 120 | 120 | 97 |
Ave. CPA (mg/day) | 56.6 | 50.4 | 73 | 45.8 | 52.9 | 81.2 |
Ave. LEU (mg/month) | 0.94 | 2.52 | 3.3 | 0.51 | 0.06 | 7.1 |